clinical trial diversity

BIO panel takes on patient recruitment, retention challenges

BIO Panel Takes on Patient Recruitment, Retention Challenges

During BIO International, a group of industry experts discussed patient recruitment and retention challenges in the panel discussion Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials on Monday, June 13. Outsourcing-Pharma spoke with Clincierge CEO Scott Gray, the moderator of the talk, to get a sneak peek at the session.

The ‘voice of the patient’ needs to be heard in clinical trials: study

The ‘Voice of the Patient’ Needs to be Heard in Clinical Trials: Study

Featured in The Science Advisory Board: Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have a limited pool of patients, contends Clincierge CEO Scott Gray. At the 2022 Biotechnology Innovation Organization (BIO) International Convention, Clincierge will release the results of an independent, institutional review …

The ‘Voice of the Patient’ Needs to be Heard in Clinical Trials: Study Read More »

Technologys Role in the Patient Experience

Technology’s Role in the Patient Experience

Healthcare and technology have always gone hand-in-hand. In fact, some of medicine’s earliest innovations are the most enduring. For clinical trials, the convergence of healthcare and technology creates a constant stream of innovation in the pursuit of novel treatments and therapies. Likewise, the pandemic and subsequent growth of decentralized trials demonstrate how technology can play an essential role in the patient experience.

SCRS Talks How the Clinical Treatment Act is Increasing Diverse Access to Trials

SCRS Talks Podcast: How the Clinical Treatment Act is Increasing Diverse Access to Trials

In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act.  This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge, …

SCRS Talks Podcast: How the Clinical Treatment Act is Increasing Diverse Access to Trials Read More »